(Allergan plc)

	AGN latest price $129.1355 (-1.25%) ($128.0910 - $131.2244) on Mon. Dec. 24, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.94% (three month average)
RSI	12
Latest Price	$129.1355(-1.25%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -2.7% a day on average for past five trading days.
Weekly Trend	AGN declines -6.3% a week on average for past two weeks.
Market Behavior	Broad based sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(49%)    ARKG(47%)    XLV(47%)    XBI(46%)    IWO(45%)
Factors Impacting AGN price	AGN will decline at least -0.97% in a week (0% probabilities).   VIXM(-25%)    TLT(-24%)    UUP(-19%)    DIA(-19%)    VXX(-14%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.97% (StdDev 1.94%)
Hourly BBV	0 ()
Intraday Trend	-0.1%

Resistance Level	$147.47
5 Day Moving Average	$135.33(-4.58%)
10 Day Moving Average	$141.73(-8.89%)
20 Day Moving Average	$147.47(-12.43%)
To recent high	-32.6%
To recent low	0%
Market Cap	$42.576b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed